Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Clinical trial NCT00352521 · COMPLETED

Trial details

NCT number: NCT00352521
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2006-04-01
Primary completion: 2006-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.